benzbromarone has been researched along with Cardiovascular Diseases in 6 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using the Korean National Health Insurance claims data (2002-17), we conducted a cohort study of 124 434 gout patients who initiated either allopurinol (n = 103 695) or benzbromarone (n = 20 739), matched on propensity score at a 5:1 ratio." | 8.02 | Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout. ( Kang, EH; Kim, SC; Park, EH; Shin, A; Song, JS, 2021) |
| "The object of this study was to evaluate the effect of uric acid lowering therapy in reducing the new development of comorbidities and the frequency of acute attacks in gout patients." | 7.80 | Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. ( Joo, H; Joo, K; Jung, KH; Kwon, SR; Lim, MJ; Park, W, 2014) |
| "Using the Korean National Health Insurance claims data (2002-17), we conducted a cohort study of 124 434 gout patients who initiated either allopurinol (n = 103 695) or benzbromarone (n = 20 739), matched on propensity score at a 5:1 ratio." | 4.02 | Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout. ( Kang, EH; Kim, SC; Park, EH; Shin, A; Song, JS, 2021) |
| "The object of this study was to evaluate the effect of uric acid lowering therapy in reducing the new development of comorbidities and the frequency of acute attacks in gout patients." | 3.80 | Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. ( Joo, H; Joo, K; Jung, KH; Kwon, SR; Lim, MJ; Park, W, 2014) |
| "Gout is a crystal deposition disease." | 2.44 | [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia]. ( Fujimori, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, EH | 1 |
| Park, EH | 1 |
| Shin, A | 1 |
| Song, JS | 1 |
| Kim, SC | 1 |
| Sawada, S | 1 |
| Kajiyama, K | 1 |
| Shida, H | 1 |
| Kimura, R | 1 |
| Nakazato, Y | 1 |
| Iguchi, T | 1 |
| Oniyama, Y | 1 |
| Ishiguro, C | 1 |
| Uyama, Y | 1 |
| Day, R | 1 |
| Lee, H | 1 |
| Graham, G | 1 |
| Williams, K | 1 |
| Joo, K | 1 |
| Kwon, SR | 1 |
| Lim, MJ | 1 |
| Jung, KH | 1 |
| Joo, H | 1 |
| Park, W | 1 |
| Hisatome, I | 1 |
| Fujimori, S | 1 |
2 reviews available for benzbromarone and Cardiovascular Diseases
| Article | Year |
|---|---|
[Impact of serum uric acid level on the cardiovascular system as a risk factor].
Topics: Adipokines; Benzbromarone; Cardiovascular Diseases; Hyperuricemia; Kidney; Organic Anion Transporter | 2010 |
[Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
Topics: Allopurinol; Benzbromarone; Cardiovascular Diseases; Gout; Gout Suppressants; Humans; Hyperuricemia; | 2008 |
4 other studies available for benzbromarone and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.
Topics: Allopurinol; Benzbromarone; Cardiovascular Diseases; Cohort Studies; Gout; Gout Suppressants; Heart | 2021 |
Cardiovascular risk of urate-lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Topics: Allopurinol; Benzbromarone; Cardiovascular Diseases; Febuxostat; Gout; Gout Suppressants; Heart Dise | 2023 |
Benzbromarone: availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt onbenzbromarone).
Topics: Animals; Benzbromarone; Cardiovascular Diseases; Diabetes Mellitus; Female; Gout; Humans; Male; Uric | 2013 |
Prevention of comorbidity and acute attack of gout by uric acid lowering therapy.
Topics: Adult; Allopurinol; Antimetabolites; Benzbromarone; Cardiovascular Diseases; Comorbidity; Diabetes M | 2014 |